It has been demonstrated that the T790M mutation can appear as a secondary mutation in tumor cells already harboring a sensitizing EGFR mutation.5 In the blood samples from those patients with the T790M mutation, the amount of T790M and EGFR-sensitizing mutations increased in parallel for some but not all patients. The gene discussed is EGFR; the disease is neoplasm.